A crisis of leadership on Ebola

Maureen Taylor

I’m sure Nero did not actually fiddle while Rome burned, but it makes a nice metaphor for the less-desirable qualities and actions of leaders and communicators during emergencies and crises. In the global/international response to the Ebola virus as it smoldered and then raged in West Africa beginning in the spring of 2014, and the

Should pharmacies sell natural health products?

Suffering from migraines, back pain, acne, diarrhea or constipation? Rexall pharmacies have a product that might help, but it’s not medication or an over-the-counter fix. Rather, it’s an IgG test called Hemocode that looks for 250 food intolerances – and costs $450. The test, which is done off-site, returns results that the pharmacist shares with

Nurses can and will care for Ebola patients

Linda Haslam-Stroud

Ontario registered nurses have a limited right to refuse unsafe work under the province’s Occupational Health and Safety Act. Still, the question remains: will nurses refuse to care for Ebola patients should we ever be faced with that scenario? As President of the Ontario Nurses’ Association (ONA), the largest nurses’ union in Canada, I can

Canadian provinces take first steps towards lower drug prices

Pan-Canadian Pharmaceutical Alliance

Prescription drugs provide important benefits to patients, and are an essential component of the health care system. They also have significant costs: Canadians spent roughly $35 billion on drugs in 2013, or about 16% of total health care spending. Drug costs have put significant strain on provincial budgets. In response, most of Canada’s provinces and

Outdated consent rules a barrier to improving children’s health care

Peter J Gill & Jonathon Maguire

The evidence to support much of children’s healthcare is limited.Ten years ago, randomized controlled trials in adults were increasing ten times faster than pediatric ones. Unfortunately, it doesn’t seem like the trend has changed and the gap in evidence between adult and children’s healthcare continues to widen. Randomized controlled trials are the best ‘fair tests’ we

Are family doctors cherry picking patients?

When Anne Lyddiatt’s family doctor retired, she went looking for a new one.  The Ingersoll, Ontario resident thought she’d found one for herself, her two daughters, and her granddaughter, and they filled out application forms with their health information. But only one of the four was accepted: the daughter who had no chronic conditions. “When

Do health care workers have a duty to treat Ebola victims?

Maureen Taylor

Every decade or so, a new or exotic infectious disease boards a flight and lands at a Western hospital, and suddenly ethical questions of risks to health care workers and “duty to treat” are front and centre. In the 1980’s and 90’s it was HIV/AIDS.  In 2003 it was SARS.  Today it’s Ebola. There is no question the

Left out in the cold: seven reasons not to freeze your eggs

Francoise Baylis

In 2012, the American Society for Reproductive Medicine (ASRM) lifted the experimental designation on human egg freezing. At this time, it was careful to indicate that freezing technology should not to be used for elective purposes, particularly as this might give young women false hope. A 2014 fact sheet prepared by the ASRM confirms that “Even in

Changes to temporary foreign worker program have unintended impacts on doctors

Reports of low-skilled Canadian workers being replaced with those from other countries spurred changes earlier this year to the Temporary Foreign Worker Program. But they’ve made it harder for areas in need of physicians as well. The system was overhauled this summer after reports that companies were misusing the program, with Canadian workers at RBC and

Did a conflict over intellectual property delay the Ebola vaccine?

Matthew Herder

Friday, October 3, 2014: A CBC headline read, “Could Ebola vaccine delay be due to an intellectual property spat?” By the next morning a colleague, Richard Gold of McGill, and I had figured out that the “IP” (intellectual property) was in fact a non-story. Whatever was delaying the start of a research trial to test

Direct to consumer genetic testing in Canada: should we be concerned?

Timothy Caulfield healthy debate blogger

The highest profile direct-to-consumer genetic testing company in the world, 23andMe, has opened shop in Canada.  In addition to providing information about your genetic ancestry (turns out I am 100% Irish), 23andMe will, after your genetic information is pulled from the required tube of spit, provide you with a whole bunch of genetic risk information

How should we measure quality in home care?

Home Care

Trevor Cranney gets 60 hours of home care a month. Though he’s happy with the quality of care he’s getting, he doesn’t think it’s enough. “I suffer from ALS, and I’m unable to feed myself, brush my hair or do anything,” says the 42-year-old, who was recently given six to nine months to live. He would like